Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:47:36 EDT Wed 09 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

C:PHRM - PharmaTher Holdings Ltd. - https://www.pharmather.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PHRM - C  152.30.05·0.05510.00.055+0.00510.05.0020.055  0.055  0.0550.415  0.04515:28:01Aug 1815 min RT 2¢
CSE - C152.30.05·0.05510.00.05    0.415  0.045Sep 0815 min
Omega - O 0.055+0.00510.05.0010.055  0.055  0.05515:28:0115 min
CXD - D 0.050.031    Jul 1415 min

Recent Trades - All 2 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:28:01O0.0550.0055,00080 National Bank1 AnonymousK
09:30:00D0.0550.0052880 National Bank7 TD SecE
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-08-18 17:11C:PHRM0.055News ReleasePharmather selects PD Labs for Personaliz3d system
2026-08-11 18:09C:PHRM0.05News ReleasePharmather launches Personaliz3D business model
2026-07-29 18:45C:PHRM0.065News ReleasePharmather, Craft Health to develop peptides
2026-07-27 18:15C:PHRM0.06News ReleasePharmather Holdings launches Personaliz3D Peptides
2026-07-21 17:59C:PHRM0.05News ReleasePharmather pushes forward with ketamine platform
2026-07-15 17:47C:PHRM0.05News ReleasePharmather sees movement in U.S. toward psychedelics
2026-05-27 18:04C:PHRM0.065News ReleasePharmather to focus on Medbotx platform
2026-05-13 10:12C:PHRM0.085News ReleasePharmaTher's Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus
2026-05-13 10:08C:PHRM0.075News ReleasePharmadrug, Pharmather to explore PD-001 for hantavirus
2026-04-29 15:40C:PHRM0.085SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-04-29 15:40C:PHRM0.085SEDAR Interim MD & ASEDAR Interim MD & A
2026-04-21 19:07C:PHRM0.11News ReleasePharmather hopes programs benefit from executive order
2026-04-20 18:57C:PHRM0.11News ReleasePharmather talks up microneedle patch opening in U.S.
2026-04-16 08:01C:PHRM0.065News ReleasePharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide Delivery
2026-04-13 17:57C:PHRM0.065News ReleasePharmather files U.S. patent for peptide patch tech
2026-03-26 17:34C:PHRM0.075News ReleasePharmather applies for provisional PatchPrint patent
2026-03-03 17:24C:PHRM0.095News ReleasePharmather to expand PharmaPatch platform
2026-02-02 19:08C:PHRM0.095News ReleasePharmather seeks to commercialize generic semaglutide
2026-01-30 00:53C:PHRM0.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-01-30 00:53C:PHRM0.09SEDAR Interim MD & ASEDAR Interim MD & A